Follow
Melania Gaggini
Melania Gaggini
Institute of Clinical Physiology
Verified email at ifc.cnr.it
Title
Cited by
Cited by
Year
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
M Gaggini, M Morelli, E Buzzigoli, RA DeFronzo, E Bugianesi, ...
Nutrients 5 (5), 1544-1560, 2013
10192013
The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis
C Saponaro, M Gaggini, F Carli, A Gastaldelli
Nutrients 7 (11), 9453-9474, 2015
4842015
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
M Gaggini, F Carli, C Rosso, E Buzzigoli, M Marietti, V Della Latta, ...
Hepatology 67 (1), 145-158, 2018
3662018
Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars
PK Luukkonen, S Sädevirta, Y Zhou, B Kayser, A Ali, L Ahonen, ...
Diabetes care 41 (8), 1732-1739, 2018
3632018
Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio Metabolism Study
A Gastaldelli, M Gaggini, RA DeFronzo
Diabetes 66 (4), 815-822, 2017
3492017
NASH in lean individuals
R Younes, E Bugianesi
Seminars in liver disease 39 (01), 086-095, 2019
2292019
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
M Masoodi, A Gastaldelli, T Hyötyläinen, E Arretxe, C Alonso, M Gaggini, ...
Nature reviews Gastroenterology & hepatology 18 (12), 835-856, 2021
2262021
Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms
C Saponaro, M Gaggini, A Gastaldelli
Current diabetes reports 15, 1-13, 2015
1682015
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease
C Rosso, K Kazankov, R Younes, S Esmaili, M Marietti, M Sacco, F Carli, ...
Journal of hepatology 71 (5), 1012-1021, 2019
1572019
Effects of probiotic supplementation on gastrointestinal, sensory and core symptoms in autism spectrum disorders: a randomized controlled trial
E Santocchi, L Guiducci, M Prosperi, S Calderoni, M Gaggini, F Apicella, ...
Frontiers in psychiatry 11, 550593, 2020
1202020
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
PK Luukkonen, S Qadri, N Ahlholm, K Porthan, V Männistö, ...
Journal of hepatology 76 (3), 526-535, 2022
1042022
HCC development is associated to peripheral insulin resistance in a mouse model of NASH
S De Minicis, L Agostinelli, C Rychlicki, GP Sorice, S Saccomanno, ...
PloS one 9 (5), e97136, 2014
1042014
Exenatide improves both hepatic and adipose tissue insulin resistance: a dynamic positron emission tomography study
A Gastaldelli, M Gaggini, G Daniele, D Ciociaro, E Cersosimo, D Tripathy, ...
Hepatology 64 (6), 2028-2037, 2016
962016
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease
C Rosso, L Mezzabotta, M Gaggini, F Salomone, R Gambino, A Marengo, ...
Hepatology 63 (1), 107-116, 2016
832016
Ectopic fat: the true culprit linking obesity and cardiovascular disease?
M Morelli, M Gaggini, G Daniele, P Marraccini, R Sicari, A Gastaldelli
Thrombosis and haemostasis 110 (10), 651-660, 2013
832013
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
I Pierantonelli, C Rychlicki, L Agostinelli, DM Giordano, M Gaggini, ...
Scientific reports 7 (1), 12200, 2017
802017
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes
M Meroni, P Dongiovanni, M Longo, F Carli, G Baselli, R Rametta, ...
EBioMedicine 52, 2020
792020
Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases
M Gaggini, C Saponaro, A Gastaldelli
Hormone molecular biology and clinical investigation 22 (1), 7-18, 2015
692015
Increased FNDC5/Irisin expression in human hepatocellular carcinoma
M Gaggini, M Cabiati, S Del Turco, T Navarra, P De Simone, F Filipponi, ...
Peptides 88, 62-66, 2017
592017
PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH
A Gastaldelli, S Sabatini, F Carli, M Gaggini, F Bril, R Belfort‐DeAguiar, ...
Liver International 41 (11), 2659-2670, 2021
582021
The system can't perform the operation now. Try again later.
Articles 1–20